Data Integrity: Understanding and Becoming Compliant with GMP and FDA Requirements

In recent years, infractions relating to data integrity have been noted in several Food and Drug Administration (FDA) warning letters, but it is not a new concept. The importance of record-keeping in drug manufacturing can be seen as far back as 1938, when the Federal Food, Drug, and Cosmetic (FDC) Act required the safety of new drugs be documented before being sold to the public, with similar regulations instigated in Europe and Japan throughout the 20th century1.


Production systems have large, inherent operational risks and are difficult to validate. Instead of only being reactive to public health disasters, preventative measures, such as the requirement for proof of claims, are taken to lower their likelihood and propagate confidence in manufacturers.